DRUG · Unmapped registry intervention
Intravenous Immunoglobulin
Find medicine records ·
Find other trials using this name
Clinical trial
Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease
NCT00299988
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPhase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer's Diseaseverified · MONDO: Alzheimer disease
Interventions
PlaceboOTHER
Sponsors & collaborators
Weill Medical College of Cornell Universitylead sponsor
Baxter BioSciencecollaborator
National Institutes of Health (NIH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00299988 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.